(Q28343759)

English

Comparative in vitro antimicrobial activities of the newly synthesized quinolone HSR-903, sitafloxacin (DU-6859a), gatifloxacin (AM-1155), and levofloxacin against Mycobacterium tuberculosis and Mycobacterium avium complex

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

0 references

Comparative in vitro antimicrobial activities of the newly synthesized quinolone HSR-903, sitafloxacin (DU-6859a), gatifloxacin (AM-1155), and levofloxacin against Mycobacterium tuberculosis and Mycobacterium avium complex (English)

0 references

0 references

Mycobacterium tuberculosis

0 references

1 reference

based on heuristic

inferred from title

Mycobacterium avium avium

1 reference

based on heuristic

inferred from title

author name string

H Tomioka

1

0 references

K Sato

2

0 references

T Akaki

3

0 references

H Kajitani

4

0 references

S Kawahara

5

0 references

M Sakatani

6

0 references

language of work or name

0 references

publication date

December 1999

0 references

Antimicrobial Agents and Chemotherapy

0 references

43

0 references

12

0 references

3001-4

0 references

Antimicrobial activities of benzoxazinorifamycin (KRM-1648) and clarithromycin against Mycobacterium avium-intracellulare complex within murine peritoneal macrophages, human macrophage-like cells and human alveolar epithelial cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=89602

20 March 2017

Spectrum of activity of levofloxacin against nontuberculous mycobacteria and its activity against the Mycobacterium avium complex in combination with ethambutol, rifampin, roxithromycin, amikacin, and clofazimine

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=89602

20 March 2017

In vitro activities of levofloxacin used alone and in combination with first- and second-line antituberculous drugs against Mycobacterium tuberculosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=89602

20 March 2017

Mycobacterium tuberculosis invades and replicates within type II alveolar cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=89602

20 March 2017

Comparative antimycobacterial activities of the newly synthesized quinolone AM-1155, sparfloxacin, and ofloxacin

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=89602

20 March 2017

Activity of levofloxacin in a murine model of tuberculosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=89602

20 March 2017

In vitro and in vivo antimycobacterial activities of a new quinolone, DU-6859a

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=89602

20 March 2017

In vitro and in vivo activities of levofloxacin against Mycobacterium tuberculosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=89602

20 March 2017

Broth microdilution testing of susceptibilities to 30 antimicrobial agents of Mycobacterium avium strains from patients with acquired immune deficiency syndrome

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=89602

20 March 2017

In vitro activity of HSR-903, a new oral quinolone, against bacteria causing respiratory infections.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=89602

29 September 2017

Double-blind evaluation of the safety and pharmacokinetics of multiple oral once-daily 750-milligram and 1-gram doses of levofloxacin in healthy volunteers

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=89602

29 September 2017

In vivo activity of HSR-903, a new fluoroquinolone, against respiratory pathogens.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=89602

29 September 2017

In vitro activity of HSR-903, a new quinolone

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=89602

29 September 2017

Epidemiology of infection by nontuberculous mycobacteria

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=89602

29 September 2017

In-vitro activities of quinolones against mycobacteria

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=89602

29 September 2017

Cytotoxicity for lung epithelial cells is a virulence-associated phenotype of Mycobacterium tuberculosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=89602

29 September 2017

Antimicrobial activities of benzoxazinorifamycin KRM-1648, clarithromycin and levofloxacin against intracellular Mycobacterium avium complex phagocytosed by murine peritoneal macrophages

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=89602

2 June 2018

In-vitro activity of fluorinated quinolones and macrolides against drug-resistant Mycobacterium tuberculosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=89602

2 June 2018

The clinical use of fluoroquinolones for the treatment of mycobacterial diseases

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=89602

2 June 2018

In vitro antimycobacterial activity of a new quinolone, levofloxacin (DR-3355).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=89602

2 June 2018

New drugs for tuberculosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/10582897

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Levofloxacin in the treatment of drug-resistant tuberculosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/10582897

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Susceptibility of Mycobacterium avium and Mycobacterium intracellulare to various antibacterial drugs

1 reference

https://pubmed.ncbi.nlm.nih.gov/10582897

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Tuberculosis into the next century. Proceedings of a symposium held on 4 February 1995 at the Liverpool School of Medicine

1 reference

https://pubmed.ncbi.nlm.nih.gov/10582897

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

PMC publication ID

0 references

PubMed publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q28343759&oldid=1955340861"